|
EVC expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.79285491902692E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.40418837352763E-12 |
| Normal-vs-Stage2 |
6.3172800324196E-12 |
| Normal-vs-Stage3 |
6.67588206937353E-12 |
| Normal-vs-Stage4 |
7.80553399692963E-12 |
| Stage1-vs-Stage2 |
2.574800E-01 |
| Stage1-vs-Stage3 |
7.356200E-01 |
| Stage1-vs-Stage4 |
5.306600E-01 |
| Stage2-vs-Stage3 |
3.945800E-01 |
| Stage2-vs-Stage4 |
5.475000E-01 |
| Stage3-vs-Stage4 |
8.020600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.4691364204682E-12 |
| Normal-vs-AfricanAmerican |
5.84399999999929E-05 |
| Normal-vs-Asian |
5.1777000464881E-09 |
| Caucasian-vs-AfricanAmerican |
1.936610E-01 |
| Caucasian-vs-Asian |
7.048200E-01 |
| AfricanAmerican-vs-Asian |
3.905600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.15127915481617E-12 |
| Normal-vs-Female |
5.54245538353371E-12 |
| Male-vs-Female |
2.074400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.63313806922361E-12 |
| Normal-vs-Age(41-60Yrs) |
7.3329120553467E-12 |
| Normal-vs-Age(61-80Yrs) |
2.70006239588838E-13 |
| Normal-vs-Age(81-100Yrs) |
1.408690E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.436400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.020170E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.978400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.759020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.433000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.796600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.318400E-01 |
| Classical-VS-Follicular |
2.3200000000001E-06 |
| Classical-VS-Other |
9.384600E-01 |
| Classical-VS-Normal |
2.33649988246043E-10 |
| Tall-VS-Follicular |
2.553800E-02 |
| Tall-VS-Other |
8.595000E-01 |
| Tall-VS-Normal |
1.2979000096891E-09 |
| Follicular-VS-Other |
3.899400E-01 |
| Follicular-VS-Normal |
1.62725388719309E-12 |
| Other-VS-Normal |
6.837400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.22453216642316E-13 |
| Normal-vs-N1 |
2.44230191626116E-11 |
| N0-vs-N1 |
6.557400E-01 |
|
|
